The clinical relevance of neurocognitive measures in addiction.
One of the major challenges in addiction treatment is relapse prevention, as rates of relapse following treatment remain very high across the main classes of drugs of abuse. Relapse prevention could be improved by a better understanding of the factors that influence treatment outcomes, including better predictors of risk of relapse following treatment. Recent developments in cognitive neuroscience point to neurocognitive measures (i.e., brain-imaging measures during cognitive-task performance) as potential predictors of relapse. These might even be better predictors than self-report measures, such as craving. We first give an overview of the current state of the field, and then discuss the outstanding challenges and future directions in this area of research.
Institute of Psychology, Erasmus University Rotterdam , Rotterdam , Netherlands ; Department of Child and Adolescent Psychiatry, VU University Medical Center , Amsterdam , Netherlands.
Reshmi
R
Marhe
Institute of Psychology, Erasmus University Rotterdam , Rotterdam , Netherlands ; Behavioural Science Institute, Radboud University Nijmegen , Nijmegen , Netherlands.
Maartje
M
Luijten
Institute of Psychology, Erasmus University Rotterdam , Rotterdam , Netherlands.
Ingmar H A
IH
Franken
addiction; attentional bias; clinical relevance; cognitive control; neurocognitive processes; substance relapse